Shopping Cart
- Remove All
- Your shopping cart is currently empty
Quinoclamine is a naphthoquinone derivative and is an NF-κB inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $30 | In Stock | |
50 mg | $40 | In Stock | |
100 mg | $64 | In Stock | |
500 mg | $155 | In Stock | |
1 g | $228 | In Stock | |
1 mL x 10 mM (in DMSO) | $44 | In Stock |
Description | Quinoclamine is a naphthoquinone derivative and is an NF-κB inhibitor. |
In vitro | Quinoclamine induces the differentiation of U-937 cells into macrophage-like cells. Quinoclamine inhibits NF-κB activities in HepG2 cells (IC50: 1.7 μM). Quinoclamine inhibits induced NF-κB activities in lung and breast cancer cell lines. Quinoclamine affects the expression levels of genes involved in cell cycle or apoptosis. Quinoclamine down-regulates the expressions of UDP glucuronosyltransferase genes involved in phase II drug metabolism. Quinoclamine (1-4 μM; 30 minutes ) inhibits endogenous NF-κB activity in HepG2 cells through the inhibition of IκB-α phosphorylation and p65 translocation [1][2]. |
Molecular Weight | 207.61 |
Formula | C10H6ClNO2 |
Cas No. | 2797-51-5 |
Smiles | NC1=C(Cl)C(=O)C2=C(C=CC=C2)C1=O |
Relative Density. | 1.49 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (240.84 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.